Gardasil 9
Medicine · European Medicines Agency · Germany
What the source publishes
- Holder
- Merck Sharp & Dohme B.V.
- Active ingredients
- Human Papillomavirus Type 31 L1 Protein, Human Papillomavirus Type 33 L1 Protein, Human Papillomavirus Type 45 L1 Protein, Human Papillomavirus Type 52 L1 Protein, Human Papillomavirus Type 58 L1 Protein, Human Papillomavirus Type 6 L1 Protein, Human Papillomavirus Type 11 L1 Protein, Human Papillomavirus Type 16 L1 Protein, Human Papillomavirus Type 18 L1 Protein, Amorphous Aluminium Hydroxyphos…
- Routes
- Intramuscular Use
- Administrative status
- listed-as-authorised
Names this record is found by
- Gardasil 9
- Human Papillomavirus Type 31 L1 Protein, Human Papillomavirus Type 33 L1 Protein, Human Papillomavirus Type 45 L1 Protein, Human Papillomavirus Type 52 L1 Protein, Human Papillomavirus Type 58 L1 Protein, Human Papillomavirus Type 6 L1 Protein, Human Papillomavirus Type 11 L1 Protein, Human Papillomavirus Type 16 L1 Protein, Human Papillomavirus Type 18 L1 Protein, Amorphous Aluminium Hydroxyphosphate Sulphate
Complete source data
{
"name": "Gardasil 9",
"holder": "Merck Sharp & Dohme B.V.",
"routes": [
"Intramuscular Use"
],
"marketed": null,
"useDomain": "unknown",
"databaseDate": "2026-10-09",
"sourceStatus": null,
"supplyRegime": null,
"listingStatus": "listed-as-authorised",
"targetSpecies": [],
"sourceRowCount": 1,
"activeSubstances": [
"Human Papillomavirus Type 31 L1 Protein, Human Papillomavirus Type 33 L1 Protein, Human Papillomavirus Type 45 L1 Protein, Human Papillomavirus Type 52 L1 Protein, Human Papillomavirus Type 58 L1 Protein, Human Papillomavirus Type 6 L1 Protein, Human Papillomavirus Type 11 L1 Protein, Human Papillomavirus Type 16 L1 Protein, Human Papillomavirus Type 18 L1 Protein, Amorphous Aluminium Hydroxyphosphate Sulphate"
],
"documentRevision": "90",
"documentReference": "EMA/518502/2018",
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "de.ema.article57"
},
"patientEligibility": "not-assessed",
"centrallyAuthorised": true,
"targetSpeciesStatus": "not-reported",
"activeSubstancesText": "Human Papillomavirus Type 31 L1 Protein, Human Papillomavirus Type 33 L1 Protein, Human Papillomavirus Type 45 L1 Protein, Human Papillomavirus Type 52 L1 Protein, Human Papillomavirus Type 58 L1 Protein, Human Papillomavirus Type 6 L1 Protein, Human Papillomavirus Type 11 L1 Protein, Human Papillomavirus Type 16 L1 Protein, Human Papillomavirus Type 18 L1 Protein, Amorphous Aluminium Hydroxyphosphate Sulphate",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"authorisationTerritory": "European Union",
"pharmacovigilanceContacts": [
{
"email": "gqppvreview@msd.com",
"phone": "+44 208 154 8000",
"masterFileLocation": "Belgium"
}
]
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=de" \
--data-urlencode "sourceId=de.ema.article57" \
--data-urlencode "id=de:ema:article57:fbf4541270d23ff92da3"